OPTImal Management of Antithrombotic Agents: OPTIMA-5
NCT04116931
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndrome (ACS)
Interventions
DRUG:
Switch ticagrelor to clopidogrel
Sponsor
The First Affiliated Hospital with Nanjing Medical University